$QBIO In mid-2020, we began the regulatory registr

$QBIO In mid-2020, we began the regulatory registration process for full commercial access in the European Union, with pan-EU approval expected in the first quarter of 2022. These efforts have seen some delay due to Brexit related regulatory requirements. In parallel, we are midway through the registration process in many other countries. Due to some legacy data from previous owners not being available in current reporting standards to complete the filings, we have begun the process of creating our own source documents to complete the filings in non-US jurisdictions. We also expect this to be completed in the first quarter of 2022.

https://www.barrons.com/articles/q-biomed-inc...1635264423

Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!